Evidence map›Paper›PMID 34961099›Full record

ReviewPlants (Basel, Switzerland)2021

Vitrification Solutions for Plant Cryopreservation: Modification and Properties.

Jiri Zamecnik, Milos Faltus, Alois Bilavcik

Open access · goldAbstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Cryopreservation by Vitrification for the Aquatic Plant Family Lemnaceae.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Biotechnological Tools for Agave Conservation.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  6. Strategies for the Conservation of Plant Genetic Resources.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. New Method for Enhancing Coconut (Plants (Basel, Switzerland) · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jiri ZamecnikCrop Research Institute, Drnovska 507, 16106 Prague, Czech Republic.
Milos FaltusCrop Research Institute, Drnovska 507, 16106 Prague, Czech Republic.ORCID 0000-0003-2217-5226
Alois BilavcikCrop Research Institute, Drnovska 507, 16106 Prague, Czech Republic.ORCID 0000-0002-8588-2924
Czech Agrifood Research Center · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many plants cannot vitrify themselves because they lack glassy state-inducing substances and/or have high water content. Therefore, cryoprotectants are used to induce vitrification. A cryoprotectant must have at least the following primary abilities: high glass-forming property, dehydration strength on a colligative basis to dehydrate plant cells to induce the vitrification state, and must not be toxic for plants. This review introduces the compounds used for vitrification solutions (VSs), their properties indicating a modification of different plant vitrification solutions, their modifications in the compounds, and/or their concentration. An experimental comparison is listed based on the survival or regeneration rate of one particular species after using more than three different VSs or their modifications. A brief overview of various cryopreservation methods using the Plant Vitrification Solution (PVS) is also included. This review can help in alert researchers to newly introduced PVSs for plant vitrification cryoprotocols, their properties, and the choice of their modifications in the compounds and/or their concentration.

Indexed as

cryoprotectantglassy statetoxicityultra-low temperature

Identifiers

PMID34961099
PMCPMC8707230
OpenAlexW3217529580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.